Yahoo
NYSE American - Delayed Quote USD

Myomo, Inc. (MYO)

1.2400 -0.0600 (-4.62%)
At close: October 30 at 4:00:00 PM EDT
1.2300 -0.0100 (-0.81%)
After hours: October 30 at 7:01:03 PM EDT
Chart Range Bar
Loading chart for MYO
  • Previous Close 1.3000
  • Open 1.2700
  • Bid 1.2000 x 20000
  • Ask 1.3400 x 20000
  • Day's Range 1.2100 - 1.2797
  • 52 Week Range 0.6050 - 1.8850
  • Volume 191,472
  • Avg. Volume 470,245
  • Market Cap (intraday) 49.114M
  • Beta (5Y Monthly) 1.58
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3500
  • Earnings Date (est.) Nov 9, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 4.64
  • Zacks Rating Neutral

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

myomo.com

194

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MYO
36.26%
S&P 500 (^GSPC)
10.73%

1-Year Return

MYO
33.33%
S&P 500 (^GSPC)
11.11%

3-Year Return

MYO
13.76%
S&P 500 (^GSPC)
81.91%

5-Year Return

MYO
87.76%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 11.7M
Earnings -4.02M
Profit Margin -34.36%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
5M
10M
-36.0%
-34.0%
-32.0%
-30.0%

Analyst Insights

View More

Analyst Price Targets

1.70
4.64 Average
1.2400 Current
10.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/27/2026
Analyst Ascendiant Capital
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 10 -> 10.5

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -33.53%

  • Return on Assets (ttm)

    -19.76%

  • Return on Equity (ttm)

    -123.76%

  • Revenue (ttm)

    43.26M

  • Net Income Avi to Common (ttm)

    -14.51M

  • Diluted EPS (ttm)

    -0.3500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.45M

  • Total Debt/Equity (mrq)

    344.47%

  • Levered Free Cash Flow (ttm)

    -2.41M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: